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To investigate the presence of Lagos bat virus (LBV)–
speciﬁ  c antibodies in megachiroptera from West Africa, we 
conducted  ﬂ   uorescent antibody virus neutralization tests. 
Neutralizing antibodies were detected in Eidolon helvum 
(37%), Epomophorus gambianus (3%), and Epomops buet-
tikoferi (33%, 2/6) from Ghana. These ﬁ  ndings conﬁ  rm the 
presence of LBV in West Africa.
B
ats host a range of lyssaviruses, depending on their 
species and locality. The genus Lyssavirus is differ-
entiated into 7 genetically divergent genotypes: classical 
rabies virus (genotype 1), Lagos bat virus (LBV; genotype 
2), Mokola virus (MOKV; genotype 3), Duvenhage virus 
(genotype 4), European bat lyssavirus (genotypes 5 and 
6), and Australian bat lyssavirus (genotype 7) (1). All but 
MOKV have been isolated from bats.
LBV and MOKV are each distributed in Africa and are 
members of phylogroup 2 within the genus Lyssavirus (1). 
Because LBV isolates (2) from African bats are increasing, 
our goal was to determine the prevalence of virus neutral-
izing antibodies against LBV in bat populations in West 
Africa.
The Study
Bats were sampled in January and May 2007 at 6 sites 
in Ghana: the center of Accra (urban habitat); the wooded 
outskirts of Accra (savannah habitat); and forested habitats 
at Pra, Kibi, Adoagyiri, and Oyibi (a plantation with wood-
land/forest border). Bats were captured by using 6–18-m 
mist nets; roosting Eidolon helvum were captured by using 
nets on poles. A sample size of 59 would provide 95% con-
ﬁ  dence of ﬁ  nding at least 1 LBV-seropositive bat in a large 
population (>5,000), given a seroprevalence of 5% and as-
suming random sampling (3). Species were identiﬁ  ed by 
using a dichotomous key (4). Captured bats were manu-
ally restrained and anesthetized by intravenous injection; 
≈0.2–1.0 mL of blood was collected from the propatagial 
vein before the bat was released. Blood was centrifuged in 
the ﬁ  eld at ambient temperature at 3,000 rpm for 15 min. 
Serum was heat treated at 56°C for 30 min and frozen at 
–70°C.
Two species, Epomophorus gambianus and E. helvum, 
were caught in sufﬁ  cient numbers (117 and 66, respective-
ly) for reasonable inferences to be made about LBV se-
roprevalence rates (Table). A standard approach was used 
to calculate 95% conﬁ  dence intervals (CIs) for seropreva-
lence (3). Because of the relatively short distances between 
study sites and the likelihood of bats mixing between these 
sites, bats of each species were considered to belong to sin-
gle populations. All but 3 E. helvum were derived from a 
colony in Accra, whereas E. gambianus were derived from 
all habitat types.
Bat serum samples were tested for virus neutralizing 
antibody against classical rabies virus (challenge virus 
standard) by using a standard ﬂ  uorescent antibody virus 
neutralization (FAVN) test (5). Antibodies to LBV were 
measured by using a modiﬁ  ed FAVN test (6). Because 
positive bat antiserum from naturally infected bats was not 
available, for positive controls we used human rabies im-
munoglobulin, LBV-positive rabbit serum, and serum from 
mice vaccinated with human diploid cell vaccine. Nega-
tive controls were negative rabbit and mouse serum. All 
samples were analyzed in duplicate and serially diluted by 
using a 3-fold series (representing reciprocal titers of 9, 27, 
81, and 243–19,683) (6).
The modiﬁ  ed FAVN test requires a cut-off threshold, 
which in prior bat lyssavirus studies has been a titer of 27, 
to avoid false-positive results (6,7). The ﬁ  rst 121 samples 
collected were tested against the challenge virus standard; 
no tested bat was seropositive at 1:3 dilutions. A mean titer 
>9 was considered positive for LBV (Figure 1; [8]).
Levels of speciﬁ  c virus neutralizing antibodies against 
LBV were higher in E. helvum (seroprevalence 37%, 95% 
CI 24%–49%) than in E. gambianus (3%, 95% CI 0%–7%). 
Of 6 Epomops buettikoferi, 2 were seropositive (30%, 95% 
CI 0%–70%). No sex differences in E. helvum seropreva-
lence were evident (χ2 1.0, p>0.9).
Because of the high level of seropositivity in E. hel-
vum, we attempted to determine a possible case reproduc-
tion rate (R0) for LBV infection in this species by using the 
equation R0 = 1/x*, where x* = proportion of susceptible 
hosts in a population (9). We assumed that infection with 
each virus within the bat populations is endemic, stable, 
and randomly dispersed; that all seropositive animals have 
lifelong immunity that is detectable serologically; and that 
seropositivity is to 1 virus. On the basis of these assump-
tions, R0 = 1.6 (95% CI 1.3–2.0).
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Conclusions
We found antibodies against LBV in healthy E. hel-
vum bats in Ghana. Previous studies have suggested that 
healthy bats develop antibodies to other lyssavirus infec-
tions (7,10,11), which may reﬂ  ect past exposure, rather than 
survival from clinical disease. LBV likely co-evolved with 
its natural megachiropteran host until a genetic stasis had 
been reached in which the virus–host relationship was in 
equilibrium. This situation would result in high seropreva-
lence rates after a wave of virus circulation in a colony. 
Nine seropositive bats (8 E. helvum, 1 E. buettikoferi) were 
apparently healthy pregnant females. These results support 
theories that lyssaviruses are endemic within speciﬁ  c bat 
populations, that they may not cause high mortality rates, 
that exposure rates of LBV between megachiroptera in Old 
World African bats are high, and that bats may breed suc-
cessfully after LBV exposure (7,8). The number of high 
reciprocal titers against LBV (Figure 1) and the history of 
LBV isolation in E. helvum suggest that LBV circulates in 
megachiroptera in Ghana. However, further work is needed 
to determine the speciﬁ  c phylogroup 2 virus and its preva-
lence within speciﬁ  c bat populations.
No previous estimate of R0 for genotype 2 Lyssavirus 
has been calculated, and although anamnesis may lead to 
no detectable antibodies in bats with immunity and a con-
sequent underestimate of R0, this value indicates the poten-
tial R0 and is comparable to values previously estimated for 
lyssavirus infections in bats (7,11). More detailed analysis 
relating to age-speciﬁ  c infection and survival rates or mode 
of transmission was precluded by the difﬁ  culty in deter-
mining the age of adult bats, the lack of juveniles in the 
sample, and the cross-sectional sample used. 
The underlying cause of the difference in seropreva-
lence between E. gambianus and E. helvum with respect 
to LBV infection is unclear. Possible explanations include 
differential susceptibilities to infection; virus–host adap-
tation; different contact with the virus, including a recent 
epidemic in the E. helvum colony; or different population 
ecology.  E. helvum resides in high-density populations 
(hundreds of thousands) (Figure 2, panel A) and migrates 
annually, compared with E. gambianus, which resides in 
less dense colonies of tens or hundreds (4). E. helvum com-
monly forms large colonies in African cities in close prox-
imity to humans and domestic animals and is a food source 
in West Africa (Figure 2, panel B). 
No investigations into infections of humans were made 
during these investigations, but lyssavirus infections in hu-
mans in Africa are underdiagnosed (12). Despite reduced 
pathogenicity of LBV in the laboratory, it has been isolated 
from dogs, cats, and a mongoose (2). Conversely, MOKV 
has caused a fatal case of encephalitis in a human (1). LBV 
and MOKV each have a substitution in the R333 glyco-
protein residue (1). Although it is not the only protein to 
determine the pathogenicity of LBV, the R333 substitution 
still remains an important marker of rabies pathogenicity. 
In conclusion, the high seroprevalence to LBV in this pop-
ulation may pose a substantial public health risk because E. 
helvum is widely distributed in Africa and a food source in 
West Africa.
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Figure 1. Antibody titers to Lagos bat virus (LBV) in 6 species of 
fruit bat in Ghana. An LBV-speciﬁ  c modiﬁ  ed ﬂ  uorescent antibody 
neutralization test was used to determine the level of antibody in 
bats; it used two 3-fold serial dilutions and derived a mean dilution 
at which the bats neutralized LBV. Bats with mean titers >9 were 
considered positive. The circle size represents the number of 
bats tested. 1, Epomops franqueti; 2, Epomophorus gambianus; 
3,  Epomops buettikoferi; 4, Eidolon helvum; 5, Hypsignathus 
monstrosus; 6, Nanonycteris veldkampii.
Table.  Bat species and their respective seroprevalence rates against phylogroups 1and 2 lyssaviruses, Ghana, 2007* 
Seroprevalence, % (95% CI, no. tested) 
Species Habitat No. caught
% Adults tested for LBV 
antibodies CVS rabies virus  LBV
Epomophorus gambianus  Savannah† 117 61 0 (49)  3 (0–7,  91) 
Eidolon helvum  Urban‡ 66 95 0 (57)  37 (24–49, 57) 
Epomops franqueti  Forest‡ 30 77 0 (3)  0 (31) 
Epomops buettikoferi  Forest‡ 9 83 0 (5)  30 (0–70, 6) 
Hypsignathus monstrosus  Forest‡ 18 56 0 (1)  0 (5) 
Nanonycteris veldkampii  Forest‡ 5 100 NT 0 (4) 
*Phylogroup 1 contains challenge virus standard (CVS), genotype 1; phylogroup 2 contains Lagos bat virus (LBV), genotype 2; CI, confidence interval; 
NT, not tested. 
†E. gambianus was caught in all habitats, including at the city colony and in plantations. 
‡A small number of these species were caught in plantations. Acknowledgments
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Figure 2. A) Density of a typical Eidolon helvum roost in the Accra 
colony. B) E. helvum as bushmeat in an Accra market.
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